In order to counter the potential impact of tariffs, it is imperative for Indian pharmaceutical companies to implement market diversification strategies. By expanding their presence in regions like Europe, Africa, and Latin America, these firms can tap into new markets and reduce their dependence on any single market. It is crucial for companies to focus on high-margin products and optimize their supply chains to ensure cost-effectiveness and efficiency. By diversifying their market reach and product offerings, Indian pharmaceutical companies can strengthen their competitive edge and ensure sustainable growth in the face of changing global trade dynamics.